Finance

Lists
Q2 2026 earnings • released • EPS beat +၁၇.၀၇% • Revenue miss -၀.၃၄%
See results
DH:NASDAQ
Definitive Healthcare Corp
၀.၆၅ US$
+၁.၀၁%
(+၀.၀၀၆၅) 1D
၀.၆၅ US$
-၀.၀၃% (-၀.၀၀၀၂၀)
Pre-market
Closed: ဩ ၁၂, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DH...
Open
၀.၆၃ US$
High
၀.၆၆ US$
Low
၀.၆၃ US$
Mkt. cap
၉.၄၇ ကုဋေ
Avg. vol.
၂.၇၇ သိန်း
Volume
၀.၀၀
52-wk high
၄.၃၅ US$
52-wk low
၀.၆၂ US$
EPS
-၁.၆၁ US$
Beta
၁.၃၅
Shares outstanding
၁၀.၆၇ ကုဋေ
No. of employees
၆၈၂
Open
၀.၆၃ US$
High
၀.၆၆ US$
Low
၀.၆၃ US$
Mkt. cap
၉.၄၇ ကုဋေ
Avg. vol.
၂.၇၇ သိန်း
Volume
၀.၀၀
52-wk high
၄.၃၅ US$
52-wk low
၀.၆၂ US$
EPS
-၁.၆၁ US$
Beta
၁.၃၅
Shares outstanding
၁၀.၆၇ ကုဋေ
No. of employees
၆၈၂
News stories
From web sources and news partners
TipRanks
TipRanks
·
ပြီးခဲ့သည့် ၁ ရက်
Definitive Healthcare Corp. Class A Faces Nasdaq Delisting Risk After Prolonged Sub‑$1 Share Price
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ ရက်
Definitive Healthcare (DH) Stock Price Slides As Revenue Shrinks And Losses Linger
TradingView
TradingView
·
ပြီးခဲ့သည့် ၁ ရက်
Definitive Healthcare Corp. Stock 12‑Month Price Target Cut to $2.03, Implies 191% Upside
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၂ ရက်
Definitive Healthcare earnings beat by $0.01, revenue fell short of estimates
Profile
Definitive Healthcare, Corp. is a publicly traded healthcare data and analytics company headquartered in Framingham, Massachusetts, United States. The company operates subscription-based products and solutions with data on healthcare organizations, providers, services, medical and scientific experts, claims, and consumers. Definitive Healthcare supports life sciences, healthcare providers, software and IT, consulting, financial services, and other organizations operating within the healthcare market. Wikipedia
About Definitive Healthcare Corp
CEO-
Employees၆၈၂
Founded၂၀၁၁
HeadquartersFramingham, မက်ဆာချူးဆက်ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitedefinitivehc.com
Analyst ratings
Based on 7 analysts giving stock ratings to DH in the past 3 months
Hold
Buy
1
Hold
4
Sell
2
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for DH in the last 3 months.
Highest
Current ၀.၆၅ US$
၃.၀၀ US$ (+၃၆၁.၄၀%)
Average
၁.၇၀ US$ (+၁၆၁.၄၆%)
Lowest
၀.၇၀ US$ (+၇.၆၆%)
Analyst
Recommendation
Action
Price target
Projected
Date
George Hill
Deutsche Bank
Hold
Maintained
၁.၀၀ US$
+၅၃.၈%
08/12/2026
David Grossman
Stifel Nicolaus
Buy
Maintained
၃.၀၀ US$
+၃၆၁.၄%
08/11/2026
Allen Lutz
Bank of America Securities
Sell
Reiterated
၀.၇၀ US$
+၇.၇%
08/11/2026
Craig Hettenbach
Morgan Stanley
Hold
Reiterated
၁.၅၀ US$
+၁၃၀.၇%
08/11/2026
David Hynes
Canaccord Genuity
Hold
Maintained
၃.၀၀ US$
+၃၆၁.၄%
08/11/2026
Ryan MacDonald
Needham
Hold
Reiterated
-
-
08/11/2026
Glen Santangelo
Barclays
Sell
Maintained
၁.၀၀ US$
+၅၃.၈%
08/11/2026
David Larsen
BTIG
Hold
Maintained
-
-
05/11/2026
Joseph Vruwink
Robert W. Baird
Hold
Maintained
၁.၁၀ US$
+၆၉.၂%
05/08/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
05/07/2026
Jeffrey Garro
Stephens
Hold
Maintained
၃.၀၀ US$
+၃၆၁.၄%
02/27/2026
Last report
၂၀၂၆ ဩ ၁၀
Fiscal period
Q2 2026
EPS / Est. (USD)
၀.၀၅ US$ / ၀.၀၄ US$
+၁၇.၀၇%beat
Revenue / Est. (USD)
၅.၅၂ ကုဋေ / ၅.၅၄ ကုဋေ
-၀.၃၄%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၆.၀၈ ကုဋေ
၆.၀၀ ကုဋေ
၆.၁၅ ကုဋေ
၅.၅၉ ကုဋေ
Cost of goods sold
၈.၈၀ သန်း
၉.၀၇ သန်း
၉.၉၄ သန်း
၉.၃၆ သန်း
Cost of revenue
၈.၈၀ သန်း
၉.၀၇ သန်း
၉.၉၄ သန်း
၉.၃၆ သန်း
Research and development expenses
၇.၉၇ သန်း
၇.၅၅ သန်း
၉.၉၅ သန်း
၆.၅၀ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၃၁ ကုဋေ
၃.၂၇ ကုဋေ
၃.၄၅ ကုဋေ
၃.၁၇ ကုဋေ
Operating expense
၅.၅၄ ကုဋေ
၅.၄၄ ကုဋေ
၅.၈၃ ကုဋေ
၅.၁၄ ကုဋေ
Total operating expenses
၆.၄၂ ကုဋေ
၆.၃၄ ကုဋေ
၆.၈၂ ကုဋေ
၆.၀၈ ကုဋေ
Operating income
-၃.၅၀ သန်း
-၃.၃၈ သန်း
-၆.၇၂ သန်း
-၄.၈၄ သန်း
Other non operating income
-၂.၉၀ သန်း
-၇.၂၅ သန်း
၁.၂၇ ကုဋေ
၆.၈၃ သန်း
EBT including unusual items
-၈.၈၁ သန်း
-၁.၇၃ ကုဋေ
-၁.၇၂ ကုဋေ
-၁၉.၅၈ ကုဋေ
EBT excluding unusual items
-၈.၁၄ သန်း
-၁.၂၀ ကုဋေ
၂.၇၁ သန်း
၆.၆၅ သိန်း
Income tax expense
၄.၅၆ သိန်း
၅.၂၄ သိန်း
-၅.၃၀ သောင်း
-၃.၄၄ သန်း
Effective tax rate
-၅.၁၈%
-၃.၀၃%
၀.၃၁%
၁.၇၅%
Other operating expenses
-
-
-
-
Net income
-၇.၅၅ သန်း
-၁.၄၈ ကုဋေ
-၉.၃၂ သန်း
-၁၃.၈၆ ကုဋေ
Net profit margin
-၁၂.၄၃%
-၂၄.၇၁%
-၁၅.၁၄%
-၂၄၇.၈၅%
Earnings per share
၀.၀၇
၀.၀၇
၀.၀၆
၀.၀၆
Interest and investment income
၁.၇၅ သန်း
၁.၆၇ သန်း
၁.၄၈ သန်း
၁.၃၀ သန်း
Interest expense
-၂.၉၉ သန်း
-၃.၀၀ သန်း
-၂.၈၇ သန်း
-၂.၆၃ သန်း
Net interest expenses
-၁.၂၄ သန်း
-၁.၃၃ သန်း
-၁.၃၈ သန်း
-၁.၃၃ သန်း
Depreciation and amortization charges
၉.၀၀ သန်း
၉.၀၈ သန်း
၉.၂၁ သန်း
၈.၃၂ သန်း
EBITDA
၁.၀၈ ကုဋေ
၁.၀၇ ကုဋေ
၇.၁၈ သန်း
၈.၄၁ သန်း
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ